These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17073627)

  • 1. Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas.
    Souza F; Freeby M; Hultman K; Simpson N; Herron A; Witkowsky P; Liu E; Maffei A; Harris PE
    Curr Med Chem; 2006; 13(23):2761-73. PubMed ID: 17073627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
    Murakami T; Fujimoto H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in molecular imaging of pancreatic beta cells.
    Lin M; Lubag A; McGuire MJ; Seliounine SY; Tsyganov EN; Antich PP; Sherry AD; Brown KC; Sun X
    Front Biosci; 2008 May; 13():4558-75. PubMed ID: 18508529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in beta-cell imaging.
    Moore A
    Eur J Radiol; 2009 May; 70(2):254-7. PubMed ID: 19261414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus.
    Di Gialleonardo V; de Vries EF; Di Girolamo M; Quintero AM; Dierckx RA; Signore A
    Endocr Rev; 2012 Dec; 33(6):892-919. PubMed ID: 22889646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches for imaging islets: recent advances and future prospects.
    Ahlgren U; Gotthardt M
    Adv Exp Med Biol; 2010; 654():39-57. PubMed ID: 20217493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas.
    Di Gialleonardo V; Signore A; Scheerstra EA; Visser AK; van Waarde A; Dierckx RA; de Vries EF
    J Nucl Med; 2012 Nov; 53(11):1755-63. PubMed ID: 23000748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
    Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pancreatic imaging in monogenic diabetes mellitus.
    Haldorsen IS; Ræder H; Vesterhus M; Molven A; Njølstad PR
    Nat Rev Endocrinol; 2011 Nov; 8(3):148-59. PubMed ID: 22124438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed?
    Hardt PD; Brendel MD; Kloer HU; Bretzel RG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S165-9. PubMed ID: 18227480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
    Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use.
    Eriksson O; Laughlin M; Brom M; Nuutila P; Roden M; Hwa A; Bonadonna R; Gotthardt M
    Diabetologia; 2016 Jul; 59(7):1340-1349. PubMed ID: 27094935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inside the pancreas: progress and challenges of human beta cell mass quantification.
    Tiedge M
    Diabetologia; 2014 May; 57(5):856-9. PubMed ID: 24599112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical imaging of islets: New possibilities by the development of infrared fluorescent proteins.
    Hörnblad A; Ahlgren U
    Islets; 2009; 1(2):163-4. PubMed ID: 21099267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-modal magnetic resonance/fluorescent zinc probes for pancreatic β-cell mass imaging.
    Stasiuk GJ; Minuzzi F; Sae-Heng M; Rivas C; Juretschke HP; Piemonti L; Allegrini PR; Laurent D; Duckworth AR; Beeby A; Rutter GA; Long NJ
    Chemistry; 2015 Mar; 21(13):5023-33. PubMed ID: 25736590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach.
    Alavi A; Werner TJ
    Diabetologia; 2018 Dec; 61(12):2512-2515. PubMed ID: 29955934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targets and probes for non-invasive imaging of β-cells.
    Jodal A; Schibli R; Béhé M
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):712-727. PubMed ID: 28025655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of
    Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE
    J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging in Type 1 Diabetes, Current Perspectives and Directions.
    Tinklepaugh J; Mamrak NE
    Mol Imaging Biol; 2023 Dec; 25(6):1142-1149. PubMed ID: 37934378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.